fbpx
Size of letters 1x
Site color
Image
Additionally
Line height
Letter spacing
Font
Embedded items (videos, maps, etc.)
 

Illya Kostin Recognized as a Leading Expert in the Industry According to Who’s Who Legal: Life Sciences 2018

24/ 04/ 2018
  Illya Kostin, partner and head of intellectual property and dispute resolution practices at Legal Alliance Company, has been named among the leading Life Sciences lawyers in the world according to Whos Who Legal: Life Sciences 2018 independent legal market research. Recognition in 3 nominations – regulatory, patent litigation and transactional – once again confirms professionalism, strong expertise, unique experience and excellent reputation of Illya Kostin and the team in these practices. The results of comprehensive annual research with peers and clients by the authoritative international guide Whos Who Legal (WWL) was published in April. This year WWL: Life Sciences 2018 recommends 1047 lawyers from 420 firms all over the world and marks those law firms and lawyers which are the most qualified in their respective regions. In particular, it features 218 transactional lawyers selected for their prominent work in life sciences, those who focus on mergers and acquisitions, IPO, securities and venture capital transactions, outsourcing and investment agreements and joint ventures; 314 regulatory law experts who advise clients and offer innovative solutions on a range of issues, from product development and manufacture to pricing, market safety and customs rules; 399 legal practitioners in the field of patent litigation from across 211 law firms worldwide, experienced at handling patent disputes in various areas including pharmaceuticals, biotechnology and medical devices. Due to deep niche expertise of our lawyers, Legal Alliance Company for a lot of years has had leading positions among Ukrainian and foreign law firms in the area of Life Sciences, which encompasses such areas of pharmaceuticals, medical products, consumer goods, medicine, veterinary medicine, cosmetics, chemistry, biotechnology, agriculture and food products.

Illya Kostin, partner and head of intellectual property and dispute resolution practices at Legal Alliance Company, has been named among the leading Life Sciences lawyers in the world according to Who’s Who Legal: Life Sciences 2018 independent legal market research. Recognition in 3 nominations – regulatory, patent litigation and transactional – once again confirms professionalism, strong expertise, unique experience and excellent reputation of Illya Kostin and the team in these practices.

The results of comprehensive annual research with peers and clients by the authoritative international guide Who’s Who Legal (WWL) was published in April.

This year WWL: Life Sciences 2018 recommends 1047 lawyers from 420 firms all over the world and marks those law firms and lawyers which are the most qualified in their respective regions. In particular, it features 218 transactional lawyers selected for their prominent work in life sciences, those who focus on mergers and acquisitions, IPO, securities and venture capital transactions, outsourcing and investment agreements and joint ventures; 314 regulatory law experts who advise clients and offer innovative solutions on a range of issues, from product development and manufacture to pricing, market safety and customs rules; 399 legal practitioners in the field of patent litigation from across 211 law firms worldwide, experienced at handling patent disputes in various areas including pharmaceuticals, biotechnology and medical devices.

Due to deep niche expertise of our lawyers, Legal Alliance Company for a lot of years has had leading positions among Ukrainian and foreign law firms in the area of Life Sciences, which encompasses such areas of pharmaceuticals, medical products, consumer goods, medicine, veterinary medicine, cosmetics, chemistry, biotechnology, agriculture and food products.

If you have found a spelling error, please, notify us by selecting that text and pressing Ctrl+Enter.

Start
in the Telegram bot
Read articles. Share in social networks
0 Shares

Spelling error report

The following text will be sent to our editors: